The Performance Linked Incentive (PLI) Schemes have showcased remarkable success, with exports under the targeted sectors exceeding Rs 3.20 lakh crore (US$ 38.5 billion). Major contributions come from...
Pharma
With policies that focus on sales performance and enhanced ease of doing business, India can aspire to replicate Chinese success in consumer goods....
As India endeavours to stem the decline in exports of key sectors like engineering goods, gems & jewellery, readymade garments and leather, it has an opportunity to capitalise on the positive trend in...
Helge Tryti, Commercial Counsellor, Royal Norwegian Embassy, elaborates on the future of Indo-Norway cooperation, which is strongly geared towards energy, marine resources green economy and shipping. ...
Tanaz Buhariwalla, Director, IDA Ireland, discusses Ireland’s key advantages as a business destination for Indian companies, including a business-friendly ecosystem, competitive costs, support for i...
Laura Demetris, Deputy Director for Investment and Marketing - South Asia at British High Commission, envisions the India-UK relationship as highly symbiotic, with the two countries responsible for ha...
Post-COVID-19, India needs to strengthen its pharma R&D ecosystem to tap into emerging drug development opportunities and changing paradigms in the new drug development framework.....
Sanjay Singh, Partner – Deal Advisory, Head of Lifesciences, KPMG in India, identifies new generics opportunities, established manufacturing ecosystem, growing penetration of health insurance and ta...
Though a new guideline released by the General Office of the State Council, China has revised the registration and approval of pharmaceutical products to fasten the process, the implementation still n...